CiNTL Pharma B.V. Launches 2026 Operations from Utrecht’s Leading Life Sciences Hub
Expanding collaboration opportunities for pharma, biotech, and public-sector partners

January 8, 2025

​

Utrecht, The Netherlands, January 8, 2026 — CiNTL Pharma B.V. today announced that has joined Utrecht Leading Life Sciences Hub, marking an important milestone in the company’s continued growth. We are proud to be among the first tenants of the newly completed Plus Ultra Utrecht, developed by Kadans Science Partner.

​

Plus Ultra Utrecht has been awarded the BREEAM-NL Outstanding certification, the highest sustainability rating for buildings in the Netherlands, reflecting its environmentally responsible design, energy efficiency, and future-proof infrastructure. Being part of this award-winning, collaborative life sciences environment reinforces our commitment to operating within ecosystems built for scientific rigor, innovation, and long-term impact.

​

As a data-driven, agentic contract research organization, CiNTL Pharma supports pharmaceutical, biotechnology, and public-sector organizations navigating complex and highly regulated clinical environments. We provide end-to-end clinical development support, from pre-clinical development through Phase I–IV, combining intelligent execution, data-driven insight, and deep regulatory expertise.

Operating from Utrecht Science Park strengthens our ability to work closely with innovators, researchers, and industry partners translating scientific advances into real-world outcomes that matter to patients and healthcare systems.

​

As we begin the year ahead, we welcome conversations with organizations exploring partnerships, advisory support, or strategic collaboration, and look forward to contributing to the continued strength of the Utrecht life sciences ecosystem.

​

About CiNTL Pharma B.V.

CiNTL Pharma is a data-driven, female-founded CRO based in the Netherlands. The company is pioneering an agentic AI platform designed to transform clinical research design, regulatory workflows, and trial execution. With a strong focus on automation and equity, CiNTL Pharma empowers pharmaceutical and biotechnology companies to run faster, smarter, and more compliant clinical trials.

​

Website: www.cintlpharma.com

 

For media inquiries, partnerships, or collaborations, please contact CiNTL Pharma Business Developement at BD@cintlpharma.com.

​